modular_finance
Sprint Bioscience announces agreement with Lilly TuneLab to accelerate drug development
Sprint Bioscience AB (publ) today announced that it has entered into an agreement with Lilly TuneLab, a collaborative AI‑driven drug discovery platform created by Eli Lilly and Company (Lilly). By joining TuneLab, Sprint Bioscience aims to amplify and accelerate the development of the company’s res…